1
0
0
(1 - 42 von 49
)
Helmholtz-Zentrum für Infektionsforschung | Helmholtz Centre for...
www.helmholtz-hzi.de
Biotech pioneer moves antibody discovery platform and cooperates with the Helmholtz Centre for Infection Research. Based on the profound expertise of YUMAB’s...
Antibody Humanization and Affinity Maturation Markets, 2030
www.marketscreener.com
Dublin, Sept. 15, The Antibody Humanization and Affinity Maturation: Services and Platforms, report has been added to Research...
Global Antibody Discovery Services and Platforms Market,
apnews.com
... and Founding Chief Scientist, BioSavita)Sanjiban K Banerjee (Director, AbGenics Life Sciences)Thomas Schirrmann (Chief Executive Officer ...
LinkedIn: Thomas Schirrmann | LinkedIn
Thomas Schirrmanns berufliches Profil anzeigen LinkedIn ist das weltweit ... General Manager bei YUMAB GmbH ... Coordination of the German NGFN2 project "Antibody Factory", Subprojects in EU FP7 "Affinity proteome" and "Affinomics" ...
Antibody Discovery: Services and Platforms Market (2nd Edition)
www.prnewswire.com
Thomas Schirrmann (Chief Executive Officer and General Manager, YUMAB) All actual figures have been sourced and analyzed from publicly ...
Antibody Discovery: Services and Platforms,
www.prnewswire.com
Antibody Discovery: Services and Platforms,
YUMAB Identifies Promising Candidate for COVID-19 Antibody Therapy
www.prnewswire.com
· Thomas Schirrmann, CEO of YUMAB. The company's CSO, André Frenzel, comments "YUMAB decided early-on to pursue multiple stratagies to ...
Team - YUMAB GmbHwww.yumab.com › company › team
www.yumab.com
Thomas Schirrmann, CEO of YUMAB. “We cannot change biological mechanisms behind the success of antibody drugs, but we can focus on fully human ...
Antibody Engineering Volume 1 - Google Books
books.google.de
Antibodies are indispensable tools for research, diagnosis, and therapy. Recombinant approaches allow the modification and improvement of nearly all antibody...
Antibody Engineering - Band 1 - Seite xiii - Google Books-Ergebnisseite
books.google.cz
743 Torsten Ru ̈lker, Doris Meier, and Thomas Schirrmann Determination of Fc-Mediated Antibody-Effector Functions by Chromium Release Assay .
Immunotherapy of Cancer von Patricia Yotnda | ISBN
www.lehmanns.de
Construction of Human Antibody Gene Libraries and Selection of Antibodies by Phage Display Thomas Schirrmann and Michael Hust 12. Identification of ...
A SARS-CoV-2 Neutralizing Antibody Selected from COVID-19 Patients by...
papers.ssrn.com
· ... Günter Roth, Andreas Hermann, Thomas Schirrmann, Stefan Dübel, André Frenzel, Joop Van den Heuvel, Luka Cicin-Sain, Maren Schubert, ...
EBSCOhost | | Production of single chain Fab (scFab)...
web.b.ebscohost.com
megaterium. Eva Jordan†, Laila Al-Halabi†, Thomas Schirrmann, Michael Hust* and ... smaller antibody fragments like the single chain Fv (scFv). Published: 27 November Microbial Cell Factories 2007, 6:38 doi:
pOPE101
download.bioon.com
Torsten Rülker, Doris Meier, and Thomas Schirrmann. 49 Determination of Fc-Mediated Antibody-Effector. Functions by Chromium Release Assay .
Production of single chain Fab (scFab) fragments in Bacillus...
microbialcellfactories.biomedcentral.com
Thomas Schirrmann, ... Microbial Cell Factories20076: Recently, the novel single chain Fab (scFab) antibody format combining properties of single chain Fv ...
Generation and analysis of the improved human HAL9/10 antibody ...bmcbiotechnol.biomedcentral.com › articles
bmcbiotechnol.biomedcentral.com
· André Frenzel & Thomas Schirrmann. Klinikum Braunschweig g GmbH, Institut für Klinische Transfusionsmedizin, ...
Production of recombinant antibody fragments in Bacillus megaterium |...
microbialcellfactories.biomedcentral.com
... Biedendieck,; Thomas Schirrmann,; Dieter Jahn and; Stefan Dübel. Microbial Cell Factories :2. https://doi.org
The influence of antibody fragment format on phage display based...
core.ac.uk
By Miriam Steinwand, Patrick Droste, Andrè Frenzel, Michael Hust, Stefan Dübel and Thomas Schirrmann. Cite. BibTex; Full citation. No static citation data.
Generation and analysis of the improved human HAL9/10 antibody phage...
link.springer.com
Antibody phage display is a proven key technology that allows the generation of human antibodies for diagnostics and therapy. From naive antibody gene...
Antibody validation and characterization – YUMABwordpress.yourmab.de › antibody-validation-and-ch...
wordpress.yourmab.de
Meetings & News ... Meet YUMAB CEO Thomas Schirrmann at the J.P. Morgan 35th Annual Healthcare Conference San Francisco (January 9-12, 2017).
BMC Biotechnology - BioMedSearch
www.biomedsearch.com
Thomas Schirrmann1, Hans-Jürgen Marschall2, Michael Hust*†1 and ... Torsten Rülker - ; Thomas Schirrmann - ; Hans pathogenic virus from a human naïve scFv antibody gene library using complete, active virus "Antibody Factory" in the NGFN2 program).
YUMAB: boosting anti-infective antibody and vaccine development |...
biopharmadealmakers.nature.com
YUMAB, a global provider of fully human monoclonal antibody discovery and development, has relocated its headquarters to Germany’s hotspot of infectious...
Thomas Schirrmann, PhD & Janice Reichert, PhD - The Antibody ...www.antibodysociety.org › thomas-schirrmann-phd...
www.antibodysociety.org
· Speaker: Thomas Schirrmann received his PhD in immunology for his work in adoptive cellular immune therapy with chimeric antigen receptor ...
Publications Konrad Büssow
www.buessow.com
Volker Jäger, Konrad Büssow, Andreas Wagner, Susanne Weber, Michael Hust, André Frenzel, and Thomas Schirrmann High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells BMC Biotechnology 2013, 13:
Construction of Human Antibody Gene Libraries and Selection of...
experiments.springernature.com
... of Human Antibody Gene Libraries and Selection of Antibodies by Phage Display. Authors: Thomas Schirrmann 1 ,. Michael Hust 1. Thomas Schirrmann 1 ,.
Construction of Human Antibody Gene Libraries and Selection ...
experiments.springernature.com
Construction of Human Antibody Gene Libraries and Selection of Antibodies by Phage Display. Thomas Schirrmann & Michael Hust , 2010, Springer Protocols ...
Generation and analysis of the improved human HAL9/10 antibody phage...
www.infona.pl
factory GmbH, Braunschweig, Germany ... Thomas Schirrmann.
Antibody Discovery Services Market to Witness Continuous Growth in...
www.rootsanalysis.com
Antibody Discovery Services Market to Witness Continuous Growth in the Coming Decade
CiteSeerX — Production of recombinant antibody fragments in Bacillus
citeseerx.ist.psu.edu
BibTeX. @MISC{Jordan07productionof, author = {Eva Jordan and Michael Hust and Andreas Roth and Rebekka Biedendieck and Thomas Schirrmann and ...
Antibody Engineering. Methods and Protocols, Second Edition. Edited...
docplayer.net
... Andre Frenzel, Torsten Meyer, Thomas Schirrmann, and Stefan Dübel Jannick Leoen, and Jürgen Haustraete 20 Monoclonal Antibody Expression in ...
Construction of Human Naive Antibody Gene Libraries | Springer ...experiments.springernature.com › articles
experiments.springernature.com
Construction of Human Naive Antibody Gene Libraries. Authors: Michael Hust Author Email 1 ,. André Frenzel 1 ,. Torsten Meyer 2 ,. Thomas Schirrmann 1 ,.
Expression of Recombinant Antibodies – topic of research paper in ...cyberleninka.org › article
cyberleninka.org
Similar topics of scientific paper in Nano-technology , author of scholarly article — André Frenzel, Michael Hust, Thomas Schirrmann. Recombinant antibody ...
Molecules | Free Full-Text | Phage Display for the Generation of...
www.mdpi.com
Twenty years after its development, antibody phage display using filamentous bacteriophage represents the most successful in vitro antibody selection...
The INNs and outs of antibody nonproprietary names - ePrints Soton
eprints.soton.ac.uk
Author: Thomas Schirrmann. Author: Richard A.J. Janssen. Author: Martin Steegmaier. Author: Jane A. Gross. Author: Andrew R.M. Bradbury. Author: Dennis R.
Rise and Fall of an Anti-MUC1 Specific Antibody
journals.plos.org
Background So far, human antibodies with good affinity and specificity for MUC1, a transmembrane protein overexpressed on breast cancers and ovarian...
YUMAB identifies promising candidate for Covid-19 antibody therapywww.biorn.org › post › yumab-identifiespromisingc...
www.biorn.org
· “This result represents a crucial milestone in development of ineffective therapy for Covid-19,”said Dr.Thomas Schirrmann, CEO of YUMAB. The ...
Recombinant antibody fragments allow repeated measurements of...
www.ncbi.nlm.nih.gov
Laila Al-Halabi, 1 Anne Balck, 2 Monika Michalzik, 2 David Fröde, 1 Stephanus Büttgenbach, 2 Michael Hust, 1Thomas Schirrmann, 1 , † * and Stefan Dübel 1 , ...
Rise and Fall of an Anti-MUC1 Specific Antibody - PLOS ONEjournals.plos.org › plosone › article › comments › j...
journals.plos.org
· Holger Thie , · Lars Toleikis , · Jiandong Li, · Reinhard von Wasielewski, · Gunther Bastert, · Thomas Schirrmann, · Isabel Tourais Esteves, · Christian ...
YUMAB Identifies Promising Candidate for COVID-19 Antibody Therapy |...
www.biospace.com
YUMAB Identifies Promising Candidate for COVID-19 Antibody Therapy - read this article along with other careers information, tips and advice on BioSpace
für die
www.academicconcepts.net
November forderte Tom Harkin, US-Senator aus dem Bundesstaat WILEY-VCH Verlag GmbH & Co Thomas Schirrmann ... Zur Bewältigung dieser Aufgabe entwickelt die Antikörperfabrik (Antibody Factory) Verfahren, mit ...
Alle Infos zum Namen "Thomas Schirrmann"
sortiert nach Relevanz / Datum